Rtw Investments »

Erasca shares owned by Rtw Investments

Quarter-by-quarter ownership of Erasca (ERAS) shares owned by Rtw Investments from 13F filings

Historical chart of Rtw Investments investment in Erasca

Tip: Access up to 7 years of quarterly data

All positions including Erasca held by Rtw Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Erasca by Rtw Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $546k 147k 3.72

More positions owned by Rtw Investments

Madrigal Pharmaceuticals (MDGL)
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Argenx Se Sponsored Adr (ARGX)
Protagonist Therapeutics (PTGX)
Natera (NTRA)
RadNet (RDNT)
Tarsus Pharmaceuticals (TARS)
Cogent Biosciences (COGT)
Penumbra (PEN)
Irhythm Technologies (IRTC)
Apogee Therapeutics (APGE)
Apellis Pharmaceuticals (APLS)
ACADIA Pharmaceuticals (ACAD)
Establishment Labs Holdings Ord (ESTA)

View all positions for Rtw Investments

Top funds holding Erasca

Frazier Life Sciences Management
VR Adviser
T. Rowe Price Investment Management
BlackRock
Suvretta Capital Management
Paradigm Biocapital Advisors
Logos Global Management
Vanguard Group
Arch Venture Corp
Vivo Capital
Siren
State Street Corporation
5AM Venture Management
Geode Capital Management
Affinity Asset Advisors

View all funds holding Erasca